ARID1A and ovarian carcinoma: ERONs fall under the category of type I carcinogenic pathway of ovarian carcinomas, usually originating from benign precursor lesions, with their molecular genetic characteristics extensively studied [8] and mutations of the ARID1A gene are most potentially associated with ERONs.